Parkinson's hallucinations research hub

A clinical trial to explore the potential of ondansetron for treating hallucinations in people with Parkinson’s disease

Visual hallucinations are common in Parkinson's disease, but current medications can cause serious side effects. This UK clinical trial tests ondansetron, an established anti-sickness medication, to see if it safely and effectively reduces hallucinations. The study aims to provide a safer, affordable treatment option through the NHS.